Animal models for COVID-19.
César Muñoz-Fontela,William E. Dowling,Simon G. P. Funnell,Pierre Stéphane Gsell,A. Ximena Riveros-Balta,Randy A. Albrecht,Hanne Leth Andersen,Ralph S. Baric,Miles W. Carroll,Marco Cavaleri,Chuan Qin,Ian Crozier,Kai Dallmeier,Leon de Waal,Emmie de Wit,Leen Delang,Erik D. Dohm,W. Paul Duprex,Darryl Falzarano,Courtney L. Finch,Matthew B. Frieman,Barney S. Graham,Lisa E. Gralinski,Kate Guilfoyle,Bart L. Haagmans,Geraldine A. Hamilton,Amy L. Hartman,Sander Herfst,Suzanne J.F. Kaptein,William B. Klimstra,Ivana Knezevic,Philip R. Krause,Jens H. Kuhn,Roger Le Grand,Mark G. Lewis,Wen-Chun Liu,Pauline Maisonnasse,Anita K. McElroy,Vincent J. Munster,Nadia Oreshkova,Angela L. Rasmussen,Joana Rocha-Pereira,Barry Rockx,Estefanía Rodríguez,Thomas F. Rogers,Francisco J. Salguero,Michael Schotsaert,Koert J. Stittelaar,Hendrik Jan Thibaut,Chien Te K. Tseng,Júlia Vergara-Alert,Martin Beer,Trevor Brasel,Jasper Fuk-Woo Chan,Adolfo García-Sastre,Johan Neyts,Stanley Perlman,Douglas S. Reed,Juergen A. Richt,Chad J. Roy,Joaquim Segalés,Seshadri S. Vasan,Seshadri S. Vasan,Ana Maria Henao-Restrepo,Dan H. Barouch +64 more
TL;DR: The findings of a World Health Organization expert working group that is developing animal models to test vaccines and therapeutic agents for the treatment of COVID-19, and their relevance for preclinical testing, are reviewed.
read more
Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a novel coronavirus into humans late in 2019 (first detected in Hubei province, China). As of 18 September 2020, SARS-CoV-2 has spread to 215 countries, has infected more than 30 million people and has caused more than 950,000 deaths. As humans do not have pre-existing immunity to SARS-CoV-2, there is an urgent need to develop therapeutic agents and vaccines to mitigate the current pandemic and to prevent the re-emergence of COVID-19. In February 2020, the World Health Organization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerate the testing of vaccines and therapeutic agents. Here we summarize the findings to date and provides relevant information for preclinical testing of vaccine candidates and therapeutic agents for COVID-19.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Establishment of a Liver-Specific Albumin–Cre Recombinase Transgenic Golden Hamster Model Using gRosa26-Targeted Dual-Fluorescent Reporter System for Hepatocyte-Specific Genetic Manipulation
Mei Dong,Jingwei Zhang,Haodong Wang,Ai-Hua Zhang,Wen-Tao Zeng,Jianmin Li +5 more
Abstract: BACKGROUND AND AIMS
Despite its superior physiological relevance to human liver metabolism and diseases, the absence of reliable tissue-specific gene manipulation systems has considerably limited genetic research in the Syrian golden hamster (Mesocricetus auratus). The Cre/loxP-based Rosa26-targeted dual-fluorescent reporter system (mT/mG) is widely utilized in murine models for accurate lineage tracing and conditional gene editing. However, such powerful genetic tools are not available for golden hamsters. Herein, we established a functional Rosa26-targeted mT/mG reporter system and a hepatocyte-specific albumin-Cre Recombinase (Alb-Cre) driver line in golden hamsters, providing an important platform for hepatocyte-specific gene manipulation.
METHODS
The Rosa26 homolog (gRosa26) was identified in the golden hamster genome. Then, a CRISPR/Cas9-based two-cell microinjection system was developed to precisely knock-in gRosa26. The dual-fluorescent Cre reporter (mT/mG) was inserted into gRosa26. Thereafter, a liver-specific Alb-Cre transgenic line was developed using murine Alb enhancer/promoter elements. Finally, Cre-mediated recombination efficiency was evaluated in double transgenic hamsters.
RESULTS
The gRosa26 locus exhibited >70 % sequence conservation with mice. Golden hamsters with the mT/mG reporter exhibited ubiquitous tdTomato expression, with efficient EGFP activation after Cre-mediated recombination. Furthermore, Alb-Cre transgenic golden hamsters exhibited hepatocyte-specific Cre expression. In double transgenic hamsters, robust hepatocyte-specific tdTomato-to-EGFP recombination was observed by postnatal days 21 and 42. This validated the functionality of the gRosa26-targeted mT/mG system and Alb-driven Cre expression.
CONCLUSIONS
We reported the development of a functional Rosa26-targeted mT/mG dual-reporter system and a liver-specific Alb-Cre driver in Syrian golden hamsters for the first time. This platform facilitates precise spatiotemporal gene editing in hepatocytes and serves as an essential genetic tool for liver research in this emerging model organism.
Metabolic Profiling from an Asymptomatic Ferret Model of SARS-CoV-2 Infection
David J. Beale,Rohan M. Shah,Rohan M. Shah,Avinash V. Karpe,Katie E. Hillyer,Alexander J. McAuley,Gough G. Au,Glenn A. Marsh,Seshadri S. Vasan,Seshadri S. Vasan +9 more
TL;DR: The utility of metabolomics applied to ferrets for further CO VID-19 research that advances early diagnosis of asymptomatic and mild clinical COVID-19 infections, in addition to assessing the effectiveness of new or re-purposed drug therapies is indicated.
Cerebrospinal Fluid Protein Markers Indicate Neuro-Damage in SARS-CoV-2-Infected Nonhuman Primates
Sudipa Maity,Meredith Mayer,Qingbo Shu,Hellmers Linh,Duran Bao,Robert V Blair,Yanlin He,Christopher J. Lyon,Tony Hu,R. Fischer,Jia Fan +10 more
TL;DR: In this paper , the authors used mass-spectrometry-based proteomics with a data-independent acquisition mode to investigate cerebrospinal fluid (CSF) proteins collected from two different nonhuman primates, Rhesus Macaque and African Green Monkeys, for the neurologic effects of the infection.
Innate immune cell activation causes lung fibrosis in a humanized model of long COVID
Lu Cui,Zhuoqing Fang,Cristabelle De Souza,Tristan Lerbs,Yuan Guan,Irene Li,Vivek Charu,Shiyu Chen,Irving L. Weissman,Gerlinde Wernig +9 more
TL;DR: In this paper , the essential genetic and immunologic perturbations occurring in patients with long COVID lung fibrosis were identified and promising therapeutic targets were revealed using systems biology and mechanistic studies in a humanized mouse model.
Predicting In Vitro and In Vivo Anti-SARS-CoV-2 Activities of Antivirals by Intracellular Bioavailability and Biochemical Activity
Jin-Wen Zhang,Mingfeng He,Qian Xie,Ailing Su,Kuangyang Yang,Lichu Liu,Jian Liang,Ziqi Li,Xiuxin Huang,Jianshu Hu,Qian Liu,Bing Song,Chun Hu,Lei Chen,Yan Wang +14 more
TL;DR: In this paper , the authors showed that both in vitro and in vivo antiviral activities of drugs can be predicted by their intracellular bioavailability and biochemical activity without using virus.
References
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
Maximilian Ackermann,Stijn E. Verleden,Mark Kuehnel,Axel Haverich,Tobias Welte,Florian Laenger,Arno Vanstapel,Christopher Werlein,Helge Stark,Alexandar Tzankov,William W. Li,Vincent W. Li,Steven J. Mentzer,Danny Jonigk +13 more
TL;DR: In this small series, vascular angiogenesis distinguished the pulmonary pathobiology of Covid-19 from that of equally severe influenza virus infection.
5.5K
The proximal origin of SARS-CoV-2.
Kristian G. Andersen,Kristian G. Andersen,Andrew Rambaut,W. Ian Lipkin,Edward C. Holmes,Robert F. Garry +5 more
TL;DR: It is shown that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus, and scenarios by which they could have arisen are discussed.
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
TL;DR: These analyses provide insights into the receptor usage, cell entry, host cell infectivity and animal origin of 2019-nCoV and may help epidemic surveillance and preventive measures against 2019- nCoV.
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo,Benjamin E. Nilsson-Payant,Wen-Chun Liu,Skyler Uhl,Daisy A. Hoagland,Rasmus Møller,Tristan X. Jordan,Kohei Oishi,Maryline Panis,David H. Sachs,Taia T. Wang,Robert E. Schwartz,Jean K. Lim,Randy A. Albrecht,Benjamin R. tenOever +14 more
TL;DR: It is proposed that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.
4.2K
Estimates of the severity of coronavirus disease 2019: a model-based analysis.
Robert Verity,Lucy C Okell,Ilaria Dorigatti,Peter Winskill,Charles Whittaker,Natsuko Imai,Gina Cuomo-Dannenburg,Hayley A Thompson,Patrick G T Walker,Han Fu,Amy Dighe,Jamie T. Griffin,Marc Baguelin,Sangeeta N. Bhatia,A Boonyasiri,Anne Cori,Zulma M. Cucunubá,Richard G. FitzJohn,Katy A. M. Gaythorpe,W Green,Arran Hamlet,Wes Hinsley,Daniel J Laydon,Gemma Nedjati-Gilani,Steven Riley,Sabine L. van Elsland,Erik M. Volz,Haowei Wang,Y Wang,Xiaoyue Xi,Christl A. Donnelly,Christl A. Donnelly,Azra C. Ghani,Neil M. Ferguson +33 more
TL;DR: These early estimates give an indication of the fatality ratio across the spectrum of COVID-19 disease and show a strong age gradient in risk of death.
4.2K
Related Papers (5)
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
Linlin Bao,Wei Deng,Baoying Huang,Hong Gao,Jiangning Liu,Lili Ren,Qiang Wei,Pin Yu,Yanfeng Xu,Feifei Qi,Yajin Qu,Fengdi Li,Qi Lv,Wenling Wang,Jing Xue,Shuran Gong,Mingya Liu,Guanpeng Wang,Shunyi Wang,Zhiqi Song,Linna Zhao,Peipei Liu,Li Zhao,Fei Ye,Huijuan Wang,Weimin Zhou,Na Zhu,Wei Zhen,Haisheng Yu,Xiaojuan Zhang,Li Guo,Lan Chen,Conghui Wang,Ying Wang,Xinming Wang,Yan Xiao,Qiangming Sun,Hongqi Liu,Fanli Zhu,Chunxia Ma,Lingmei Yan,Mengli Yang,Jun Han,Wenbo Xu,Wenjie Tan,Xiaozhong Peng,Qi Jin,Guizhen Wu,Chuan Qin +48 more